Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

O. Philippe Chambon


  • Large Shareholder at Irhythm Technologies Inc. (IRTC), 2016-10-25
  • Large Shareholder at Mei Pharma Inc. (MEIP), 2015-03-26
  • Large Shareholder at Versartis Inc. (VSAR), 2014-12-22
  • Large Shareholder at Durata Therapeutics Inc. (DRTX), 2014-11-18
  • Large Shareholder at Chimerix Inc (CMRX), 2014-03-20
  • Large Shareholder at Concert Pharmaceuticals Inc. (CNCE), 2014-02-21
  • Other at Oxford Immunotec Global Plc (OXFD), 2013-12-03
  • Other at Relypsa Inc (RLYP), 2013-11-21
  • Director at Nxstage Medical Inc. (NXTM), 2013-04-02
  • Large Shareholder, Director at Epocrates Inc (EPOC), 2013-03-14
  • Large Shareholder at World Heart Corp (WHRT), 2012-08-06
  • Other at Icagen Inc (ICGN), 2011-07-29
  • Other at Transcept Pharmaceuticals Inc (TSPT), 2011-07-20
  • Director at Auxilium Pharmaceuticals Inc (AUXL), 2011-05-25
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
NXTM $19.28 74,401 Director 1,146,301 2012-03-16 Filing
NXTM $18.94 22,473 Director 1,220,702 2012-03-05 Filing
NXTM $18.58 20,110 Director 2,105,587 2011-09-14 Filing
NXTM $18.42 53,102 Director 2,125,697 2011-09-08 Filing
NXTM $17.79 34,892 Director 2,178,799 2011-09-01 Filing